Tenet Healthcare Corporation (THC) Q3 2026 earnings review

Tenet cuts hospital labor costs, but contract timing drives raise

Tenet Healthcare, the operator of US hospitals and surgery centers, beat its third-quarter profit plan mostly by finishing a billing contract handoff two months early. Moving the CommonSpirit transition to October pulled $147 million of profit into the quarter, driving three-quarters of Chief Executive Saum Sutaria's $195 million full-year Adjusted EBITDA raise. Excluding that timing boost, profit still beat what the company's own plan pointed to because hospital labor costs fell, but by our math the new outlook has revenue growth slowing to about 2% in the fourth quarter.

At a glance
Revenue, excluding contract timing+4.6% by our math (+6.5% as reported)
Adjusted EBITDA, excluding contract timing+9.9% by our math (+23.3% as reported)
Profit per share, excluding one-offs$6.64 +79.5% from a year ago
Full-year Adjusted EBITDA outlookRaised $195M middle of the range: $5.125B (+12.2%)

⚖️ Verdict: ⚪ Neutral

The story is unchanged because lower hospital labor costs offset worsening patient mix and a reliance on one-time contract gains. Cutting salaries and benefits by 3 percentage points of revenue lifted clean hospital margins by 1 point. The bad news: losing insured ACA exchange patients held hospital pricing growth near zero, and outpatient surgery case volumes fell again, leaving the surgery unit's full-year profit plan flat.

The question now is whether structural cost cuts can cover the simultaneous loss of the CommonSpirit billing contract, ACA exchange patients and uncapped state Medicaid payments in 2027. Either labor efficiencies and higher-priced joint surgeries fill the gap, or hospital profits step down once the 2026 contract windfalls end. The initial 2027 outlook next quarter will settle it.

🐂 Bull Case

🟢🟢 strengthening MARGIN

Labor Control Lifts Hospital Margins

Tenet operates acute care hospitals and outpatient surgery centers across the United States. Chief executive Saum Sutaria said the company's technology and operating initiatives are keeping costs down. Total salaries, wages and benefits fell 1.4% from a year ago to $2.17 billion, dropping by 3.1 percentage points of revenue to 38.6%, even as same-hospital patient admissions rose 2.8% and emergency room visits grew 4.0%.

That cost control lifted profit in the hospital division even after stripping out a one-time contract windfall. By our math, excluding $147 million of early contract handoff gains, hospital Adjusted EBITDA — earnings before interest, taxes, depreciation and one-offs — grew 10.5% to $671 million. The clean hospital margin reached 16.1%, up 1.0 percentage point from a year ago despite a $6 million drop in prior-year Medicaid catch-up payments.

What to watch: salaries and benefits as a share of revenue in the fourth quarter. Holding that ratio below 40% while winter patient volumes rise would show the cost savings can offset next year's insurance headwinds.

🟢 strengthening CAPITAL ALLOCATION

Buybacks and Refinancing Cut Share Count and Debt

Tenet is using its cash flow to shrink both its share count and its debt load. The healthcare operator bought back 970,000 shares for $255 million in the third quarter, bringing nine-month repurchases to 7.99 million shares for $1.62 billion. That reduced the diluted share count by 9.0% from a year ago to 80.6 million, turning a 23.3% rise in Adjusted EBITDA into 79.5% growth in profit per share.

In September, the Dallas-based group also issued $2.0 billion of 6.25% notes due in 2034 to pay off $1.5 billion of debt due in 2027 and $500 million due in 2028. Net debt fell to 2.11 times Adjusted EBITDA from 2.33 times in June. What to watch: fourth-quarter share repurchases against the 83 million full-year share outlook. Buying more shares while keeping leverage near 2.1 times would lift 2027 profit per share.

🐻 Bear Case

🔴🔴 persistent GROWTH contradicts narrative

Contract Timing Drove Three-Quarters of the Raise

"Our outperformance in the third quarter of 2026 was driven by sustained strength in same-store revenue growth and effective expense management," chief executive Saum Sutaria said. Yet most of the beat came from Conifer, Tenet's hospital billing unit, which is ending its contract with CommonSpirit Health.

Tenet moved the handoff deadline up by two months to October 30, 2026. That shift pulled $97 million of operating revenue and $50 million of "efficiencies from the revised timeline" into the third quarter, adding $147 million to Adjusted EBITDA and $646 million to separate contract termination revenue.

  • Reported Q3 Adjusted EBITDA: $1,355 million, up 23.3% from a year ago
  • Clean Q3 Adjusted EBITDA: $1,208 million, up 9.9% by our math
  • Full-year Adjusted EBITDA outlook raise: $195 million at the middle of the range

The company called the $97 million revenue boost "timing-related adjustments and as such, do not impact total or full year 2026 expectations". Because the $147 million windfall accounts for three-quarters of the $195 million full-year profit raise, the outlook implies fourth-quarter revenue growth slows to 1.7% by our math.

What to watch: the 2027 revenue and profit outlook for the hospital division when fourth-quarter results arrive. That forecast will show how much profit disappears once the CommonSpirit billing payments stop.

🔴 persistent MACRO

ACA Exchange Drop Holds Back Hospital Pricing

Enhanced federal subsidies for Affordable Care Act (ACA) insurance exchanges expired at the end of 2025, causing fewer insured patients to visit Tenet's hospitals. The company said third-quarter hospital revenue and profit faced an "unfavorable payer mix due to lower exchange admissions". While ”strength in commercial employer net patient revenues” helped, same-hospital revenue per adjusted admission — the average price collected per patient — edged up just 0.2% from a year ago.

That 0.2% gain marks a sharp slowdown from 3.3% growth in the second quarter and 5.9% a year ago. When patients lose exchange coverage, they still visit the emergency room, where traffic jumped 4.0%, but the hospital collects far less money for their care. What to watch: uninsured and charity care costs in the third-quarter filing. A faster rise than last quarter's 27% jump would show the subsidy loss is taking a bigger bite out of hospital prices.

🔴 persistent GROWTH

Outpatient Surgery Volumes Keep Shrinking

Tenet's Ambulatory Care division, United Surgical Partners International (USPI), runs 535 outpatient surgery centers and 25 surgical hospitals. Same-facility revenue grew 4.5% from a year ago, down from 5.0% in the second quarter and 8.3% a year ago. Surgical case volumes at centers open at least a year fell 1.5%, marking the fifth decline in the last seven quarters.

USPI kept revenue growing through a 6.1% rise in revenue per case, driven by "higher acuity and favorable service mix" as doctors perform more complex joint surgeries. Even so, Tenet left its full-year outpatient Adjusted EBITDA forecast unchanged at $2.16 billion to $2.22 billion, putting all of the company's profit raise in the hospital unit. What to watch: fourth-quarter same-facility surgical case volumes. Another drop would leave USPI reliant on price increases and clinic buyouts for growth.

🔴 persistent DISCLOSURE

Risks this quarter didn't answer

Four standing risks around government rules and insurance payments had no new numbers in the earnings release and await the quarterly filing or the conference call.

  • Total supplemental Medicaid revenue: the release noted $32 million of prior-year payments, but the full quarterly state-directed payment figure — which faces federal caps starting in 2027 — only appears in the quarterly filing.
  • ACA exchange share of revenue: not in the release after falling to 5.5% in the second quarter; the call remarks typically give this number.
  • 2027 outpatient drug rule math: management previously deferred sizing the impact of the proposed 340B drug payment clawback until year-end.
  • Insurance claim denials: accounts receivable rose 3.1% from a year ago to $2.60 billion, and the release gave no update on payer disputes.

💲 Other KPIs

Free cash flow, excluding one-offs (26Q3) $1,102 million
⇗ accelerating

Cash left after capital spending, excluding termination payments and restructuring costs, jumped 41.1% from a year ago and more than doubled from $444 million in the second quarter. For the first nine months, it rose 12.3% to $2.52 billion, prompting Tenet to lift its full-year cash flow target by $100 million.

Capital expenditures (26Q3) $198 million
⇘ decelerating

Spending on property and equipment fell 29.3% from a year ago, dropping to 3.5% of revenue from 5.3% in the third quarter of 2025. Hospital capital spending fell to $158 million from $242 million a year ago, while surgery center spending ticked up to $40 million from $38 million.

Accounts receivable (26Q3) $2,595 million
⇒ stable

Money owed by insurers and patients rose 3.1% from a year ago and dipped slightly from $2,608 million in June. Because unpaid bills grew more slowly than the 6.5% rise in third-quarter revenue, working capital was less of a drag on operating cash flow than in the first half.

🔮 Guidance

FY26 Net operating revenues $22,050–22,450 million
🠅 raised from $21,900–22,500 million
⇘ decelerating

Raised. The middle of the full-year sales plan moved up $50 million to $22.25 billion, or 4.4% growth from 2025. By our math, that leaves fourth-quarter revenue at $5.62 billion, up just 1.7% from a year ago as the $97 million third-quarter billing catch-up reverses. It is the second raise this year, smaller than last quarter's $300 million increase.

FY26 Adjusted EBITDA $5,050–5,200 million
🠅 raised from $4,830–5,030 million
⇘ decelerating

Raised. The middle of the range rose $195 million to $5.125 billion, or 12.2% growth for the year, following a $295 million raise in the second quarter. By our math, the plan leaves $1.304 billion for the fourth quarter, up 10.2% from a year ago against 23.3% growth in the third quarter.

FY26 Adjusted EBITDA margin 22.9–23.2%
🠅 raised from 22.1–22.4%
⇘ decelerating

Raised. The middle of the margin plan rose 0.8 percentage points to 23.05%. By our math, the outlook implies a 23.2% margin in the fourth quarter, down from 24.1% in the third quarter when the Conifer contract handoff boosted profit, but up from 21.4% in the fourth quarter of 2025.

FY26 Net income available to common shareholders $2,973–3,078 million
🠅 raised from $2,869–3,024 million
⇘ decelerating

Raised. The middle of the net profit outlook rose $79 million to $3.026 billion, which includes $1.65 billion of pre-tax revenue from ending the CommonSpirit billing contract. By our math, that leaves $498 million of net income for the fourth quarter, down from $1.00 billion in the third quarter as termination revenue steps down to $178 million.

FY26 Diluted earnings per share $35.82–37.08
🠅 raised from $34.57–36.43
⇘ decelerating

Raised. The middle of the reported profit per share forecast increased by $0.95 to $36.45, helped by lower restructuring estimates and a share count assumption held at about 83 million. By our math, that leaves $6.37 per share for the fourth quarter, compared with $12.41 in the third quarter and $4.22 a year ago.

FY26 Adjusted net income $1,830–1,910 million
🠅 raised from $1,685–1,800 million
⇘ decelerating

Raised. Excluding the CommonSpirit termination fee and one-off charges, the middle of the profit forecast rose $127.5 million to $1.87 billion. By our math, the target leaves $399 million for the fourth quarter, down from $535 million in the third quarter and slightly below the $413 million earned in the fourth quarter of 2025.

FY26 Adjusted diluted earnings per share $22.05–23.01
🠅 raised from $20.30–21.69
⇘ decelerating

Raised. The middle of the profit per share plan, excluding one-offs, rose $1.535 to $22.53, or 34.3% growth for the year. By our math, that leaves $5.03 per share in the fourth quarter, up 7.0% from $4.70 a year ago, a sharp step down from 79.5% growth in the third quarter.

FY26 Net cash provided by operating activities $3,885–4,315 million
🠅 raised from $3,840–4,290 million
⇘ decelerating

Raised. The middle of the operating cash flow forecast moved up $35 million to $4.10 billion. With $3.507 billion already collected in the first nine months, the plan implies $593 million of operating cash flow in the fourth quarter by our math, down from $731 million a year ago due to tax payments.

FY26 Adjusted net cash provided by operating activities $3,525–3,925 million
🠅 raised from $3,425–3,825 million
⇘ decelerating

Raised. Excluding $540 million of contract termination cash and restructuring payments, the middle of the operating cash outlook rose $100 million to $3.725 billion. By our math, that leaves $655 million for the fourth quarter, compared with $1.30 billion in the third quarter and $768 million in the fourth quarter of 2025.

FY26 Capital expenditures $700–800 million
🠆 unchanged from $700–800 million
⇗ accelerating

Unchanged. The capital spending plan stays at $750 million at the middle of the range, where it has sat all year. Because the hospital operator spent only $546 million in the first nine months, the plan implies fourth-quarter capital spending of $204 million by our math, up from $198 million in the third quarter.

FY26 Free cash flow $3,185–3,515 million
🠅 raised from $3,140–3,490 million
⇘ decelerating

Raised. The middle of the reported free cash flow range increased by $35 million to $3.35 billion. By our math, subtracting nine-month free cash flow of $2.961 billion leaves $389 million for the fourth quarter, compared with $367 million in the fourth quarter of 2025.

FY26 Adjusted free cash flow $2,825–3,125 million
🠅 raised from $2,725–3,025 million
⇘ decelerating

Raised. The middle of the cash flow forecast, excluding one-offs, rose $100 million to $2.975 billion, following a $225 million increase last quarter. By our math, that leaves $451 million for the fourth quarter, compared with $1.102 billion in the third quarter and $404 million a year ago.

FY26 Ambulatory Net operating revenues $5,530–5,670 million
🠆 unchanged from $5,500–5,700 million
⇒ stable

Unchanged at the middle. The surgery center revenue range narrowed by $30 million on each side, keeping the middle at $5.60 billion. By our math, that leaves $1.521 billion for the fourth quarter, up 6.1% from a year ago, while same-facility revenue growth remains guided at 3.0% to 6.0%.

FY26 Ambulatory Adjusted EBITDA $2,160–2,220 million
🠆 unchanged from $2,160–2,220 million
⇘ decelerating

Unchanged. Outpatient surgery profit stays at $2.19 billion at the middle of the range, with noncontrolling interest profit held at $865 million to $895 million. By our math, that implies $627 million of segment Adjusted EBITDA in the fourth quarter, up 8.1% from a year ago against 9.1% growth in the third quarter.

FY26 Hospital Net operating revenues $16,520–16,780 million
🠅 raised from $16,400–16,800 million
⇘ decelerating

Raised. The middle of the hospital revenue plan rose $50 million to $16.65 billion, while full-year inpatient and adjusted admissions growth targets stayed at 1.0% to 2.0%. By our math, that leaves $4.102 billion for the fourth quarter, up 0.2% from a year ago as the third-quarter Conifer revenue catch-up reverses.

FY26 Hospital Adjusted EBITDA $2,890–2,980 million
🠅 raised from $2,670–2,810 million
⇘ decelerating

Raised. The middle of the hospital profit target rose $195 million to $2.935 billion, accounting for the entire company-wide profit raise. By our math, that leaves $677 million for the fourth quarter, up 12.3% from a year ago, after the third quarter included $147 million from the early Conifer contract handoff.

FY26 Non-operating and below-the-line items Tax $1,135–1,170M; Interest $815–825M; D&A $865–915M
🠅 raised from Tax $1,075–1,130M; Interest $800–810M; D&A $875–925M
⇒ stable

Raised on taxes and interest. Income tax expense rose $50 million at the middle on higher profit, and interest expense rose $15 million after September's bond refinancing, while depreciation fell $10 million. Unconsolidated affiliate earnings ($265–275 million), noncontrolling interest income ($910–960 million) and cash distributions ($900–970 million) were all unchanged.

❓ Key Questions

What is Conifer's 2027 profit base after CommonSpirit leaves?

The CommonSpirit billing handoff finishes on October 30, 2026, ending $1.65 billion of termination revenue and third-quarter transition gains of $147 million. Investors still have no revenue or profit figure for the remaining billing business in 2027.

How big was the total supplemental Medicaid base in Q3?

The release disclosed $32 million of prior-year Medicaid catch-up payments, but not total quarterly revenue from state-directed payment programs. That total ran at $447 million in the second quarter and faces federal caps starting in 2027.

How fast did ACA exchange revenue shrink this quarter?

Lower exchange admissions held same-hospital revenue per admission growth to just 0.2% from a year ago. Management previously reported exchange revenue fell 17% to 5.5% of total sales in the second quarter, and the third-quarter figure will show if the drop worsened.

Why did outpatient surgical case volumes fall 1.5%?

Same-facility surgical cases at USPI have declined in five of the last seven quarters, and management left the segment's full-year profit outlook unchanged. Investors need to know whether lower-acuity procedures are leaving or commercial patient demand is softening.